We study how the host adaptive immune response coevolves with pathogens, especially in ways relevant to epidemiological and evolutionary forecasting, vaccine design, and pathogen diversity. Our work is computational, and we collaborate closely with immunologists and epidemiologists.
Katie is interviewed by the Atlantic on COVID-19 vaccines and the fate of Delta. In the past few months, the lab has contributed to other stories in STAT, Scientific American, the Atlantic, the Chicago Tribune, the New York Times, and other media.
Feb. 1, 2022
Sarah publishes "A Scientist's Guide to Understanding Omicron" with Jesse Bloom in the New York Times.
Dec. 12, 2021
The potential beneficial effects of vaccination on the evolution of antigenically evolving pathogens in American Naturalist (2022)
Of variants and vaccines in Cell (2021)
Improvements in Severe Acute Respiratory Syndrome Coronavirus 2 testing cascade in the United States: data from serial cross-sectional assessments in Clinical Infectious Diseases (2021)
Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality in Nature Medicine (2021)